A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.

The endocrine effects of 125 mg (low dose) aminoglutethimide (AG) twice daily (b.d.) were compared with those of 125 mg AG + 20 mg hydrocortisone (HC) b.d. in 23 and 45 postmenopausal patients with advanced breast cancer, respectively. The patients in each group were drawn from two separate populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Dowsett, M., Harris, A. L., Stuart-Harris, R., Hill, M., Cantwell, B. M., Smith, I. E., Jeffcoate, S. L.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1985
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977250/
https://www.ncbi.nlm.nih.gov/pubmed/2933050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977250/
https://www.ncbi.nlm.nih.gov/pubmed/2933050

Ejemplares similares